11.05.2015 22:59:46
|
Pfizer Acquires Minority Equity Interest In AM-Pharma - Quick Facts
(RTTNews) - Pfizer Inc. (PFE) announced that it has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. AM-Pharma B.V. is a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase for inflammatory diseases.
The option becomes exercisable upon completion of a Phase II trial of recAP in the treatment of Acute Kidney Injury (AKI) related to sepsis. Results from the current Phase II trial for recAP are expected in the second half of 2016.
Pfizer has made an upfront payment of $87.5 million for the minority equity interest and exclusive option, with additional potential payments of up to $512.5 million upon option exercise and potential launch of any product that may result from the agreement.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
Analysen zu Pfizer Inc.mehr Analysen
07.03.25 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG | |
05.02.25 | Pfizer Neutral | JP Morgan Chase & Co. |
Aktien in diesem Artikel
Pfizer Inc. | 23,57 | -0,30% |
|